Ibotta to Participate in Upcoming Investor Conferences
DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA), the leading technology company providing digital promotions and performance marketing solutions, announced today that company executives will participate in the following investor events:
- On Sept. 4, 2024 at 12:50 p.m. PT / 3:50 p.m. ET, CEO Bryan Leach and CFO Sunit Patel will participate in a fireside chat at the Citi 2024 Global TMT Conference.
- On Sept. 11, 2024 at 3:05 p.m. PT / 6:05 p.m. ET, CEO Bryan Leach will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference.
Audio webcasts of the events will be available on the investor relations section of the Ibotta website at http://investors.ibotta.com.
About Ibotta ("I bought a...")
Ibotta (NYSE: IBTA) is the leading provider of digital promotions for CPG brands, reaching over 200 million consumers through a network of publishers called the Ibotta Performance Network (IPN). The IPN allows marketers to influence what people buy, and where and how often they shop – all while paying only when their campaigns directly result in a sale. American shoppers have earned over $2 billion through the IPN since 2012. Ibotta is headquartered in Denver, and has been listed as a top place to work by The Denver Post and Inc. Magazine.
Contact
Corporate Communications
Hilary O’Byrne, hilary.obyrne@ibotta.com
Investor Relations
Shalin Patel, shalin.patel@ibotta.com
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks